ArticleCancer chemotherapy and pharmacology2013

Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes.

Jill M Kolesar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.